Cambridge Investment Research Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,542
| Closed | -$231K | – | 3042 |
|
|
2022
Q1 | $231K | Hold |
9,542
| – | – | ﹤0.01% | 2757 |
|
|
2021
Q4 | $223K | Sell |
9,542
-2,314
| -20% | -$54.1K | ﹤0.01% | 2781 |
|
|
2021
Q3 | $197K | Sell |
11,856
-200
| -2% | -$3.32K | ﹤0.01% | 2822 |
|
|
2021
Q2 | $294K | Sell |
12,056
-294
| -2% | -$7.17K | ﹤0.01% | 2487 |
|
|
2021
Q1 | $319K | Buy |
+12,350
| New | +$319K | ﹤0.01% | 2233 |
|